AHEALTH Stock Overview
An investment holding company, engages in the development, manufacture, marketing, distribution, and wholesaling of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Apex Healthcare Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM2.89 |
| 52 Week High | RM3.42 |
| 52 Week Low | RM2.34 |
| Beta | 0.38 |
| 1 Month Change | -4.93% |
| 3 Month Change | -2.03% |
| 1 Year Change | 9.75% |
| 3 Year Change | 49.48% |
| 5 Year Change | 107.66% |
| Change since IPO | 1,331.04% |
Recent News & Updates
Recent updates
Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation
May 08
Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025
Aug 28Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09
Apr 19Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09
Feb 25Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year
Aug 24Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly
May 11Is Apex Healthcare Berhad (KLSE:AHEALTH) A Smart Pick For Income Investors?
Apr 08Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)
Mar 11Does Apex Healthcare Berhad (KLSE:AHEALTH) Deserve A Spot On Your Watchlist?
Feb 26Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?
Feb 11
These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well
Jan 25Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio
Jan 07Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?
Dec 20Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment
Dec 05Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters
Nov 20Shareholder Returns
| AHEALTH | MY Pharmaceuticals | MY Market | |
|---|---|---|---|
| 7D | -1.4% | -2.3% | 1.6% |
| 1Y | 9.7% | -4.9% | 19.1% |
Return vs Industry: AHEALTH exceeded the MY Pharmaceuticals industry which returned -4.9% over the past year.
Return vs Market: AHEALTH underperformed the MY Market which returned 19.1% over the past year.
Price Volatility
| AHEALTH volatility | |
|---|---|
| AHEALTH Average Weekly Movement | 4.2% |
| Pharmaceuticals Industry Average Movement | 3.4% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in MY Market | 11.0% |
| 10% least volatile stocks in MY Market | 2.6% |
Stable Share Price: AHEALTH has not had significant price volatility in the past 3 months.
Volatility Over Time: AHEALTH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 976 | Kirk Kee | www.apexhealthcare.com.my |
Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesaling of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates through three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, oral liquids and suspensions, creams, and sterile eye drops under the Xepa brand name.
Apex Healthcare Berhad Fundamentals Summary
| AHEALTH fundamental statistics | |
|---|---|
| Market cap | RM2.08b |
| Earnings (TTM) | RM394.92m |
| Revenue (TTM) | RM938.55m |
5.3x
P/E Ratio2.2x
P/S RatioIs AHEALTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AHEALTH income statement (TTM) | |
|---|---|
| Revenue | RM938.55m |
| Cost of Revenue | RM723.52m |
| Gross Profit | RM215.03m |
| Other Expenses | -RM179.89m |
| Earnings | RM394.92m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.55 |
| Gross Margin | 22.91% |
| Net Profit Margin | 42.08% |
| Debt/Equity Ratio | 0.2% |
How did AHEALTH perform over the long term?
See historical performance and comparison